Ghrelin: Is It an Active Player in Disease or Just a Bystander Biomarker?

This review examines whether ghrelin's changes in disease states (inflammation, cardiovascular, GI disorders) represent active disease participation or passive biomarker changes — concluding it's likely an active player with therapeutic implications.

Lago, Francisca et al.·Vitamins and hormones·2005·Moderate EvidenceReview
RPEP-01061ReviewModerate Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Ghrelin changes in various disease states (cardiovascular, inflammatory, GI, metabolic) likely represent active physiological responses with functional consequences, not passive biomarker changes — supporting therapeutic ghrelin modulation in disease.

Key Numbers

How They Did This

review study on ghrp, hormone-optimization.

Why This Research Matters

Relevant for ghrp, hormone-optimization, inflammation, cardiovascular.

The Bigger Picture

Advances peptide research with clinical implications.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Ghrelin changes in various disease states (cardiovascular, inflammatory, GI, metabolic) likely represent active physiological responses with functiona
Evidence Grade:
moderate evidence.
Study Age:
Published in 2005.
Original Title:
Ghrelin, the same peptide for different functions: player or bystander?
Published In:
Vitamins and hormones, 71, 405-32 (2005)
Database ID:
RPEP-01061

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Ghrelin: Is It an Active Player in Disease or Just a Bystander Biomarker?

What was found?

This review examines whether ghrelin's changes in disease states (inflammation, cardiovascular, GI disorders) represent active disease participation or passive biomarker changes — concluding it's likely an active player with therapeutic implications.

Read More on RethinkPeptides

Cite This Study

RPEP-01061·https://rethinkpeptides.com/research/RPEP-01061

APA

Lago, Francisca; Gonzalez-Juanatey, José Ramón; Casanueva, Felipe F; Gómez-Reino, Juan; Dieguez, Carlos; Gualillo, Oreste. (2005). Ghrelin, the same peptide for different functions: player or bystander?. Vitamins and hormones, 71, 405-32.

MLA

Lago, Francisca, et al. "Ghrelin, the same peptide for different functions: player or bystander?." Vitamins and hormones, 2005.

RethinkPeptides

RethinkPeptides Research Database. "Ghrelin, the same peptide for different functions: player or..." RPEP-01061. Retrieved from https://rethinkpeptides.com/research/lago-2005-ghrelin-the-same-peptide

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.